世界のウイルス保存溶液市場インサイト及び予測(不活性化ウイルス輸送液、非活性化ウイルス輸送液)

◆英語タイトル:Global Virus Preservation Solution Market Insights, Forecast to 2028

QYResearchが発行した調査報告書(QY22JLX10252)◆商品コード:QY22JLX10252
◆発行会社(リサーチ会社):QYResearch
◆発行日:2022年7月(※2025年版があります。お問い合わせください。)
◆ページ数:117
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,900 ⇒換算¥744,800見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD7,350 ⇒換算¥1,117,200見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD9,800 ⇒換算¥1,489,600見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

COVID-19のパンデミックにより、ウイルス保存溶液のグローバル市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx%で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にウイルス保存溶液の世界市場のxxx%を占める「不活性化ウイルス輸送液」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx%CAGRで成長すると予測されています。一方、「病院」セグメントは、この予測期間を通じてxxx%のCAGRに変更されます。
ウイルス保存溶液の中国市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx%であり、中国とヨーロッパはそれぞれxxx%とxxx%です。中国の割合は2028年にxxx%に達し、対象期間を通じてxxx%のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx%、xxx%、xxx%になる見通しです。ヨーロッパのウイルス保存溶液市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx%になる見通しです。

ウイルス保存溶液のグローバル主要企業には、Thermo Fisher Scientific、Longhorn Vaccines and Diagnostics、EKF Diagnostics Holdings、Mylab、Rapid Test Methods Ltd.、CellTreat、Labnet、Foxx Life Sciences、Heathrow Scientific、Motic Microscopy、VistaLab、Memmert、VH Bio Limited、Babio Corp、Improve Medical Instruments、Beyotimeなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx%の市場シェアを占めています。

ウイルス保存溶液市場は、種類と用途によって区分されます。世界のウイルス保存溶液市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年~2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
不活性化ウイルス輸送液、非活性化ウイルス輸送液

【用途別セグメント】
病院、診療所、その他

【掲載地域】
北米:アメリカ、カナダ
ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋:日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米:メキシコ、ブラジル、アルゼンチン
中東・アフリカ:トルコ、サウジアラビア、UAE

【目次(一部)】

・調査の範囲
- ウイルス保存溶液製品概要
- 種類別市場(不活性化ウイルス輸送液、非活性化ウイルス輸送液)
- 用途別市場(病院、診療所、その他)
- 調査の目的
・エグゼクティブサマリー
- 世界のウイルス保存溶液販売量予測2017-2028
- 世界のウイルス保存溶液売上予測2017-2028
- ウイルス保存溶液の地域別販売量
- ウイルス保存溶液の地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別ウイルス保存溶液販売量
- 主要メーカー別ウイルス保存溶液売上
- 主要メーカー別ウイルス保存溶液価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模(不活性化ウイルス輸送液、非活性化ウイルス輸送液)
- ウイルス保存溶液の種類別販売量
- ウイルス保存溶液の種類別売上
- ウイルス保存溶液の種類別価格
・用途別市場規模(病院、診療所、その他)
- ウイルス保存溶液の用途別販売量
- ウイルス保存溶液の用途別売上
- ウイルス保存溶液の用途別価格
・北米市場
- 北米のウイルス保存溶液市場規模(種類別、用途別)
- 主要国別のウイルス保存溶液市場規模(アメリカ、カナダ)
・ヨーロッパ市場
- ヨーロッパのウイルス保存溶液市場規模(種類別、用途別)
- 主要国別のウイルス保存溶液市場規模(ドイツ、フランス、イギリス、イタリア、ロシア)
・アジア太平洋市場
- アジア太平洋のウイルス保存溶液市場規模(種類別、用途別)
- 主要国別のウイルス保存溶液市場規模(日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア)
・中南米市場
- 中南米のウイルス保存溶液市場規模(種類別、用途別)
- 主要国別のウイルス保存溶液市場規模(メキシコ、ブラジル、アルゼンチン)
・中東・アフリカ市場
- 中東・アフリカのウイルス保存溶液市場規模(種類別、用途別)
- 主要国別のウイルス保存溶液市場規模(トルコ、サウジアラビア)
・企業情報
Thermo Fisher Scientific、Longhorn Vaccines and Diagnostics、EKF Diagnostics Holdings、Mylab、Rapid Test Methods Ltd.、CellTreat、Labnet、Foxx Life Sciences、Heathrow Scientific、Motic Microscopy、VistaLab、Memmert、VH Bio Limited、Babio Corp、Improve Medical Instruments、Beyotime
・産業チェーン及び販売チャネル分析
- ウイルス保存溶液の産業チェーン分析
- ウイルス保存溶液の原材料
- ウイルス保存溶液の生産プロセス
- ウイルス保存溶液の販売及びマーケティング
- ウイルス保存溶液の主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- ウイルス保存溶液の産業動向
- ウイルス保存溶液のマーケットドライバー
- ウイルス保存溶液の課題
- ウイルス保存溶液の阻害要因
・主な調査結果

Market Analysis and Insights: Global Virus Preservation Solution Market
Due to the COVID-19 pandemic, the global Virus Preservation Solution market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Inactivated Virus Transport Medium accounting for % of the Virus Preservation Solution global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospital segment is altered to an % CAGR throughout this forecast period.
China Virus Preservation Solution market size is valued at US$ million in 2021, while the US and Europe Virus Preservation Solution are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Virus Preservation Solution landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Virus Preservation Solution include Thermo Fisher Scientific, Longhorn Vaccines and Diagnostics, EKF Diagnostics Holdings, Mylab, Rapid Test Methods Ltd., CellTreat, Labnet, Foxx Life Sciences and Heathrow Scientific, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Virus Preservation Solution Scope and Segment
Virus Preservation Solution market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Virus Preservation Solution market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Inactivated Virus Transport Medium
Non-Inactivated Virus Transport Medium
Segment by Application
Hospital
Clinic
Other
By Company
Thermo Fisher Scientific
Longhorn Vaccines and Diagnostics
EKF Diagnostics Holdings
Mylab
Rapid Test Methods Ltd.
CellTreat
Labnet
Foxx Life Sciences
Heathrow Scientific
Motic Microscopy
VistaLab
Memmert
VH Bio Limited
Babio Corp
Improve Medical Instruments
Beyotime
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE

❖ レポートの目次 ❖

1 Study Coverage
1.1 Virus Preservation Solution Product Introduction
1.2 Market by Type
1.2.1 Global Virus Preservation Solution Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Inactivated Virus Transport Medium
1.2.3 Non-Inactivated Virus Transport Medium
1.3 Market by Application
1.3.1 Global Virus Preservation Solution Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Virus Preservation Solution Sales Estimates and Forecasts 2017-2028
2.2 Global Virus Preservation Solution Revenue Estimates and Forecasts 2017-2028
2.3 Global Virus Preservation Solution Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Virus Preservation Solution Sales by Region
2.4.1 Global Virus Preservation Solution Sales by Region (2017-2022)
2.4.2 Global Sales Virus Preservation Solution by Region (2023-2028)
2.5 Global Virus Preservation Solution Revenue by Region
2.5.1 Global Virus Preservation Solution Revenue by Region (2017-2022)
2.5.2 Global Virus Preservation Solution Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Virus Preservation Solution Sales by Manufacturers
3.1.1 Global Top Virus Preservation Solution Manufacturers by Sales (2017-2022)
3.1.2 Global Virus Preservation Solution Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Virus Preservation Solution in 2021
3.2 Global Virus Preservation Solution Revenue by Manufacturers
3.2.1 Global Virus Preservation Solution Revenue by Manufacturers (2017-2022)
3.2.2 Global Virus Preservation Solution Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Virus Preservation Solution Revenue in 2021
3.3 Global Virus Preservation Solution Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Virus Preservation Solution Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Virus Preservation Solution Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Virus Preservation Solution Sales by Type
4.1.1 Global Virus Preservation Solution Historical Sales by Type (2017-2022)
4.1.2 Global Virus Preservation Solution Forecasted Sales by Type (2023-2028)
4.1.3 Global Virus Preservation Solution Sales Market Share by Type (2017-2028)
4.2 Global Virus Preservation Solution Revenue by Type
4.2.1 Global Virus Preservation Solution Historical Revenue by Type (2017-2022)
4.2.2 Global Virus Preservation Solution Forecasted Revenue by Type (2023-2028)
4.2.3 Global Virus Preservation Solution Revenue Market Share by Type (2017-2028)
4.3 Global Virus Preservation Solution Price by Type
4.3.1 Global Virus Preservation Solution Price by Type (2017-2022)
4.3.2 Global Virus Preservation Solution Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Virus Preservation Solution Sales by Application
5.1.1 Global Virus Preservation Solution Historical Sales by Application (2017-2022)
5.1.2 Global Virus Preservation Solution Forecasted Sales by Application (2023-2028)
5.1.3 Global Virus Preservation Solution Sales Market Share by Application (2017-2028)
5.2 Global Virus Preservation Solution Revenue by Application
5.2.1 Global Virus Preservation Solution Historical Revenue by Application (2017-2022)
5.2.2 Global Virus Preservation Solution Forecasted Revenue by Application (2023-2028)
5.2.3 Global Virus Preservation Solution Revenue Market Share by Application (2017-2028)
5.3 Global Virus Preservation Solution Price by Application
5.3.1 Global Virus Preservation Solution Price by Application (2017-2022)
5.3.2 Global Virus Preservation Solution Price Forecast by Application (2023-2028)
6 North America
6.1 North America Virus Preservation Solution Market Size by Type
6.1.1 North America Virus Preservation Solution Sales by Type (2017-2028)
6.1.2 North America Virus Preservation Solution Revenue by Type (2017-2028)
6.2 North America Virus Preservation Solution Market Size by Application
6.2.1 North America Virus Preservation Solution Sales by Application (2017-2028)
6.2.2 North America Virus Preservation Solution Revenue by Application (2017-2028)
6.3 North America Virus Preservation Solution Market Size by Country
6.3.1 North America Virus Preservation Solution Sales by Country (2017-2028)
6.3.2 North America Virus Preservation Solution Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Virus Preservation Solution Market Size by Type
7.1.1 Europe Virus Preservation Solution Sales by Type (2017-2028)
7.1.2 Europe Virus Preservation Solution Revenue by Type (2017-2028)
7.2 Europe Virus Preservation Solution Market Size by Application
7.2.1 Europe Virus Preservation Solution Sales by Application (2017-2028)
7.2.2 Europe Virus Preservation Solution Revenue by Application (2017-2028)
7.3 Europe Virus Preservation Solution Market Size by Country
7.3.1 Europe Virus Preservation Solution Sales by Country (2017-2028)
7.3.2 Europe Virus Preservation Solution Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Virus Preservation Solution Market Size by Type
8.1.1 Asia Pacific Virus Preservation Solution Sales by Type (2017-2028)
8.1.2 Asia Pacific Virus Preservation Solution Revenue by Type (2017-2028)
8.2 Asia Pacific Virus Preservation Solution Market Size by Application
8.2.1 Asia Pacific Virus Preservation Solution Sales by Application (2017-2028)
8.2.2 Asia Pacific Virus Preservation Solution Revenue by Application (2017-2028)
8.3 Asia Pacific Virus Preservation Solution Market Size by Region
8.3.1 Asia Pacific Virus Preservation Solution Sales by Region (2017-2028)
8.3.2 Asia Pacific Virus Preservation Solution Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Virus Preservation Solution Market Size by Type
9.1.1 Latin America Virus Preservation Solution Sales by Type (2017-2028)
9.1.2 Latin America Virus Preservation Solution Revenue by Type (2017-2028)
9.2 Latin America Virus Preservation Solution Market Size by Application
9.2.1 Latin America Virus Preservation Solution Sales by Application (2017-2028)
9.2.2 Latin America Virus Preservation Solution Revenue by Application (2017-2028)
9.3 Latin America Virus Preservation Solution Market Size by Country
9.3.1 Latin America Virus Preservation Solution Sales by Country (2017-2028)
9.3.2 Latin America Virus Preservation Solution Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Virus Preservation Solution Market Size by Type
10.1.1 Middle East and Africa Virus Preservation Solution Sales by Type (2017-2028)
10.1.2 Middle East and Africa Virus Preservation Solution Revenue by Type (2017-2028)
10.2 Middle East and Africa Virus Preservation Solution Market Size by Application
10.2.1 Middle East and Africa Virus Preservation Solution Sales by Application (2017-2028)
10.2.2 Middle East and Africa Virus Preservation Solution Revenue by Application (2017-2028)
10.3 Middle East and Africa Virus Preservation Solution Market Size by Country
10.3.1 Middle East and Africa Virus Preservation Solution Sales by Country (2017-2028)
10.3.2 Middle East and Africa Virus Preservation Solution Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Corporation Information
11.1.2 Thermo Fisher Scientific Overview
11.1.3 Thermo Fisher Scientific Virus Preservation Solution Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Thermo Fisher Scientific Virus Preservation Solution Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Thermo Fisher Scientific Recent Developments
11.2 Longhorn Vaccines and Diagnostics
11.2.1 Longhorn Vaccines and Diagnostics Corporation Information
11.2.2 Longhorn Vaccines and Diagnostics Overview
11.2.3 Longhorn Vaccines and Diagnostics Virus Preservation Solution Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Longhorn Vaccines and Diagnostics Virus Preservation Solution Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Longhorn Vaccines and Diagnostics Recent Developments
11.3 EKF Diagnostics Holdings
11.3.1 EKF Diagnostics Holdings Corporation Information
11.3.2 EKF Diagnostics Holdings Overview
11.3.3 EKF Diagnostics Holdings Virus Preservation Solution Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 EKF Diagnostics Holdings Virus Preservation Solution Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 EKF Diagnostics Holdings Recent Developments
11.4 Mylab
11.4.1 Mylab Corporation Information
11.4.2 Mylab Overview
11.4.3 Mylab Virus Preservation Solution Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Mylab Virus Preservation Solution Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Mylab Recent Developments
11.5 Rapid Test Methods Ltd.
11.5.1 Rapid Test Methods Ltd. Corporation Information
11.5.2 Rapid Test Methods Ltd. Overview
11.5.3 Rapid Test Methods Ltd. Virus Preservation Solution Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Rapid Test Methods Ltd. Virus Preservation Solution Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Rapid Test Methods Ltd. Recent Developments
11.6 CellTreat
11.6.1 CellTreat Corporation Information
11.6.2 CellTreat Overview
11.6.3 CellTreat Virus Preservation Solution Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 CellTreat Virus Preservation Solution Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 CellTreat Recent Developments
11.7 Labnet
11.7.1 Labnet Corporation Information
11.7.2 Labnet Overview
11.7.3 Labnet Virus Preservation Solution Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Labnet Virus Preservation Solution Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Labnet Recent Developments
11.8 Foxx Life Sciences
11.8.1 Foxx Life Sciences Corporation Information
11.8.2 Foxx Life Sciences Overview
11.8.3 Foxx Life Sciences Virus Preservation Solution Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Foxx Life Sciences Virus Preservation Solution Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Foxx Life Sciences Recent Developments
11.9 Heathrow Scientific
11.9.1 Heathrow Scientific Corporation Information
11.9.2 Heathrow Scientific Overview
11.9.3 Heathrow Scientific Virus Preservation Solution Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Heathrow Scientific Virus Preservation Solution Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Heathrow Scientific Recent Developments
11.10 Motic Microscopy
11.10.1 Motic Microscopy Corporation Information
11.10.2 Motic Microscopy Overview
11.10.3 Motic Microscopy Virus Preservation Solution Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Motic Microscopy Virus Preservation Solution Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Motic Microscopy Recent Developments
11.11 VistaLab
11.11.1 VistaLab Corporation Information
11.11.2 VistaLab Overview
11.11.3 VistaLab Virus Preservation Solution Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 VistaLab Virus Preservation Solution Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 VistaLab Recent Developments
11.12 Memmert
11.12.1 Memmert Corporation Information
11.12.2 Memmert Overview
11.12.3 Memmert Virus Preservation Solution Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Memmert Virus Preservation Solution Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Memmert Recent Developments
11.13 VH Bio Limited
11.13.1 VH Bio Limited Corporation Information
11.13.2 VH Bio Limited Overview
11.13.3 VH Bio Limited Virus Preservation Solution Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 VH Bio Limited Virus Preservation Solution Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 VH Bio Limited Recent Developments
11.14 Babio Corp
11.14.1 Babio Corp Corporation Information
11.14.2 Babio Corp Overview
11.14.3 Babio Corp Virus Preservation Solution Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Babio Corp Virus Preservation Solution Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Babio Corp Recent Developments
11.15 Improve Medical Instruments
11.15.1 Improve Medical Instruments Corporation Information
11.15.2 Improve Medical Instruments Overview
11.15.3 Improve Medical Instruments Virus Preservation Solution Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Improve Medical Instruments Virus Preservation Solution Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Improve Medical Instruments Recent Developments
11.16 Beyotime
11.16.1 Beyotime Corporation Information
11.16.2 Beyotime Overview
11.16.3 Beyotime Virus Preservation Solution Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 Beyotime Virus Preservation Solution Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Beyotime Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Virus Preservation Solution Industry Chain Analysis
12.2 Virus Preservation Solution Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Virus Preservation Solution Production Mode & Process
12.4 Virus Preservation Solution Sales and Marketing
12.4.1 Virus Preservation Solution Sales Channels
12.4.2 Virus Preservation Solution Distributors
12.5 Virus Preservation Solution Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Virus Preservation Solution Industry Trends
13.2 Virus Preservation Solution Market Drivers
13.3 Virus Preservation Solution Market Challenges
13.4 Virus Preservation Solution Market Restraints
14 Key Findings in The Global Virus Preservation Solution Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のウイルス保存溶液市場インサイト及び予測(不活性化ウイルス輸送液、非活性化ウイルス輸送液)(Global Virus Preservation Solution Market Insights, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。